BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Arthritis
,
Kidney
,
Holistic medicine
,
Valproic acid
,
rs4950928
,
ERBB2
,
Angiogenesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Myeloid Leukemia
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
S100A8
DNTT
PCDH9
HBG2
CFD
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
PILON_KLF1_TARGETS_DN
PUJANA_BRCA1_PCC_NETWORK
FISCHER_DREAM_TARGETS
DODD_NASOPHARYNGEAL_CARCINOMA_DN
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Acute myeloid leukemia - PBMC gene expression profiles of BCOR mutant and wildtype samples
Gleevec treatment of BCR-ABL positive and negative leukemia cell lines
Leukemia cell lines with low or high expression of the poor prognostic marker EVI1
Acute myeloid leukemia cell lines treated with all-trans-retinoic acid and/or tranylcypromine
Cytogenetic risk of acute myeloid leukemia
Explore Curated Studies Results
Literature
Most Relevant Literature
Assessing eligibility for treatment in acute myeloid leukemia in 2023.
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia.
Parbendazole as a promising drug for inducing differentiation of acute myeloid leukemia cells with v…
How I treat refractory and relapsed acute myeloid leukemia.
A novel therapeutic strategy: the significance of exosomal miRNAs in acute myeloid leukemia.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Biomarkers in Patients With Acute Myeloid Leukemia
Dexamethasone in Refractory or First Relapsed Acute Myeloid Leukemia
SEL24/MEN1703 in Patients With Acute Myeloid Leukemia
Frequency and Risk Factors of Acute Myeloid Leukemia
Sequential Conditioning in Haploidentical Transplantation for Refractory Acute Myeloid Leukemia
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ